Inpatient Constipation Among Migraine Patients Prescribed Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies and Standard of Care Antiepileptic Drugs: A Retrospective Cohort Study in a United States Electronic Health Record Database

被引：0
|
作者：
Andrea K. Chomistek
Veena Hoffman
Robert Urman
Karminder S. Gill
Stephen M. Ezzy
Li Zhou
Andrew S. Park
Brett Loop
Sandra Lopez-Leon
Peter McAllister
Florence T. Wang
机构：
[1] Optum,Rutgers Center for Pharmacoepidemiology and Treatment Science
[2] Amgen Inc,undefined
[3] Novartis Pharmaceuticals Corp,undefined
[4] Rutgers University,undefined
[5] New England Institute for Neurology and Headache,undefined
来源：
Pain and Therapy | 2022年 / 11卷
关键词：
Migraine; Constipation; CGRP; Monoclonal antibodies; Antiepileptic drugs; Electronic health record;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1415 / 1437
页数：22
相关论文
共 30 条
  • [21] Author’s Reply to Zhou et al: Comment on “Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population”Comment on Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular MigraineT. Miwa
    Toru Miwa
    CNS Drugs, 2025, 39 (1) : 109 - 110
  • [22] Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study
    Varnado, Oralee J.
    Brady, Brenna L.
    Zagar, Anthony J.
    Robles, Yvonne P.
    Hoyt, Margaret
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 69 - 88
  • [23] Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Claims Analysis Study
    Schwedt, Todd J.
    Lee, Jae
    Knievel, Kerry
    McVige, Jennifer
    Wang, Weiying
    Wu, Zheng
    Gillard, Patrick
    Shah, Darshini
    Blumenfeld, Andrew M.
    TOXICON, 2022, 214 : S68 - S69
  • [24] The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics
    Remenciute, Monika
    Varzaityte, Greta
    Zemgulyte, Gintare
    ACTA MEDICA LITUANICA, 2024, 31 (01) : 41 - 51
  • [25] Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
    Sun, Wenfang
    Li, Yali
    Xia, Binbin
    Chen, Jing
    Liu, Yang
    Pang, Jingyao
    Liu, Fang
    Cheng, Hua
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [26] Health care resource utilization and costs associated with treatment among patients initiating calcitonin gene-related peptide inhibitors vs other preventive migraine treatments in the United States
    Varnado, Oralee J.
    Manjelievskaia, Janna
    Ye, Wenyu
    Perry, Allison
    Schuh, Kory
    Wenzel, Richard
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (08): : 818 - 829
  • [27] PATIENT UTILIZATION AND SWITCHING PATTERNS OF PATIENT ASSISTANCE PROGRAMS (PAPS) FOR MONOCLONAL ANTIBODIES TARGETING THE CALCITONIN GENE-RELATED PEPTIDE (CGRP) PATHWAY FOR MIGRAINE PREVENTION: A RETROSPECTIVE COHORT STUDY
    Stockl, K. M.
    Multani, J. K.
    Urman, R.
    Bensink, M.
    Wade, R. L.
    Khodavirdi, A. C.
    Lu, J.
    Gill, K.
    VALUE IN HEALTH, 2022, 25 (07) : S485 - S486
  • [28] Use of medications for migraine treatment and healthcare utilization among adults with migraine before and after 3 months of initial exposure to a calcitonin gene-related peptide monoclonal antibody: A retrospective cohort study
    Coughlin, M.
    Sicignano, N.
    Rush, T.
    Harris, L.
    Litalien, G. J.
    Coric, V
    Yood, M. U.
    Cook, G. A.
    HEADACHE, 2022, 62 : 89 - 90
  • [29] REAL-WORLD PERSISTENCE IN PATIENTS TREATED WITH ONABOTULINUMTOXINA AND CALCITONIN GENE-RELATED PEPTIDE MONOCLONAL ANTIBODIES (CGRP MABS) FOR MIGRAINE: A LARGE US ADMINISTRATIVE CLAIMS DATABASE STUDY
    Ta, Jamie
    Tung, Amy
    Wang, Weiying
    Oliveri, David
    Gillard, Patrick
    CEPHALALGIA, 2020, 40 : 89 - 89
  • [30] Real-World Persistence in Patients Treated With Onabotulinumtoxin-A or Calcitonin Gene-Related Peptide Monoclonal Antibodies (CGRP mAbs) for Migraine: A Large US Administrative Claims Database Study
    Ta, J.
    Tung, A.
    Wang, W.
    Oliveri, D.
    Gillard, P. J.
    HEADACHE, 2020, 60 : 80 - 80
123